Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0673
Source ID: NCT00048451
Associated Drug: Paricalcitol
Title: Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Renal Insufficiency, Chronic
Interventions: DRUG: paricalcitol
Outcome Measures: Primary: The efficacy endpoint is achievement of two consecutive > or = 30% decreases from baseline iPTH levels. |
Sponsor/Collaborators: Sponsor: Abbott
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 68
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2002-02
Completion Date:
Results First Posted:
Last Update Posted: 2006-08-02
Locations: Tucson Therapeutic Research Institute, Inc., Tucson, Arizona, 85712, United States|Pasadena, California, 91105, United States|California Institute of Renal Research, San Diego, California, 92120, United States|Nephrology Educational Services and Research, Inc., Tarzana, California, 91356, United States|Phoenix Internal Medicine Associates, Waterbury, Connecticut, 06708, United States|University of Florida, Gainesville, Florida, 32610, United States|Miami Kidney Group, Miami, Florida, 33143, United States|ICSL Clinical Studies, Sarasota, Florida, 34232, United States|Genesis Clinical Research Corporation, Tampa, Florida, 33614, United States|Evanston Northwestern Healthcare, Evanston, Illinois, 60201, United States|Medisphere Medical Research Center, Evansville, Indiana, 47714, United States|Ochsner Clinic Chronic Dialysis, New Orleans, Louisiana, 70121, United States|Biolab Research, LLC, Rockville, Maryland, 20852, United States|The Rogosin Institute, New York, New York, 10021, United States|Dialysis Clinic, Inc., Cincinnati, Ohio, 45206, United States|Kidney Associates, Houston, Texas, 77030, United States|Texas Tech University Health Science Center, Lubbock, Texas, 79430, United States|University of Texas Health Science Center, San Antonio, Texas, 78229, United States|Wojskowy Instytut Medyczny, Warszawa, Poland
URL: https://clinicaltrials.gov/show/NCT00048451

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress